New Dako Omnis RTU antibodies
Introduction of 13 new high quality FLEX RTU antibodies for Dako Omnis.
Navigating the complexity of PD-L1 testing
CAP Today Webinar: Promises and pitfalls in lung cancer with Keith M. Kerr and Technical Brief on PD-L1 with Anika Eklund.
Review of Breast Cancer Diagnosis
In collaboration with leading experts, Agilent publishes a new comprehensive review on breast cancer diagnostic testing.
Leading the way
in PD-L1 testing
Introducing the first and only FDA-approved test to assess patients with NSCLC for KEYTRUDA® (pembrolizumab).
Results you can trust
The first and only FDA-approved PD-L1 test for use in both non-squamous NSCLC and melanoma for OPDIVO® (nivolumab).
Breast Cancer Review
New comprehensive review on breast cancer diagnostic testing.
Sixth Edition of IHC Guidebook
Read the sixth edition of the popular educational guidebook, used by pathology laboratories worldwide.
Events and Congresses
Meet us at congresses and events around the world.